PRGO
Perrigo Company plc
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · IE
$14.92
+4.56%Forward multiples
Based on analyst estimates
- P/E forward
- 6.32x
- P/E 2026E
- 6.65x
- P/E 2027E
- 6.05x
- P/E 2028E
- 5.47x
- P/S forward
- 0.52x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.82x
- Price / sales
- 0.50x
- Price / cash flow
- 8.22x
Enterprise value
- Enterprise value
- $5.0B
- EV / sales
- 1.20x
- EV / EBITDA
- -4.05x
- EV / EBIT
- 23.10x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026